BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 33002448)

  • 1. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
    Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
    Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
    Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
    Jiang T; Chen J; Fu H; Wu K; Yao Y; Eyi JUM; Matesa RA; Obono MMO; Du W; Tan H; Lin M; Li J
    Malar J; 2019 Mar; 18(1):101. PubMed ID: 30914041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo.
    Ruh E; Bateko JP; Imir T; Taylan-Ozkan A
    Malar J; 2018 Jan; 17(1):17. PubMed ID: 29316929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
    Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
    Chauvin P; Menard S; Iriart X; Nsango SE; Tchioffo MT; Abate L; Awono-Ambéné PH; Morlais I; Berry A
    J Antimicrob Chemother; 2015 Sep; 70(9):2566-71. PubMed ID: 26080363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prevalence of highly sulfadoxine-resistant dihydropteroate synthase alleles in Plasmodium falciparum isolates in Benin.
    Svigel SS; Adeothy A; Kpemasse A; Houngbo E; Sianou A; Saliou R; Patton ME; Dagnon F; Halsey ES; Tchevoede A; Udhayakumar V; Lucchi NW
    Malar J; 2021 Feb; 20(1):72. PubMed ID: 33546703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Frequency Mutations in
    Yan H; Feng J; Yin JH; Huang F; Kong XL; Lin KM; Zhang T; Feng XY; Zhou SS; Cao JP; Xia ZG
    Front Cell Infect Microbiol; 2021; 11():673194. PubMed ID: 34568082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Evidence for
    Wedam J; Tacoli C; Gai PP; Siegert K; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Devi R; Gai P; Mockenhaupt FP
    Am J Trop Med Hyg; 2018 Dec; 99(6):1508-1510. PubMed ID: 30398146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.
    Baraka V; Ishengoma DS; Fransis F; Minja DT; Madebe RA; Ngatunga D; Van Geertruyden JP
    Malar J; 2015 Nov; 14():439. PubMed ID: 26542942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017.
    Hussien M; Abdel Hamid MM; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
    PLoS One; 2020; 15(8):e0235401. PubMed ID: 32817665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
    Berzosa P; Esteban-Cantos A; García L; González V; Navarro M; Fernández T; Romay-Barja M; Herrador Z; Rubio JM; Ncogo P; Santana-Morales M; Valladares B; Riloha M; Benito A
    Malar J; 2017 Jan; 16(1):28. PubMed ID: 28086777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.
    Dosoo DK; Bailey JA; Asante KP; Oppong FB; Niaré K; Opoku-Mensah J; Owusu-Agyei S; Greenwood B; Chandramohan D
    PLoS One; 2022; 17(8):e0271489. PubMed ID: 35939419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
    Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
    Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.
    Ghanchi NK; Ursing J; Beg MA; Veiga MI; Jafri S; Mårtensson A
    Malar J; 2011 Jan; 10():18. PubMed ID: 21272384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
    Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
    Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun State, Southwest Nigeria.
    Fagbemi KA; Adebusuyi SA; Nderu D; Adedokun SA; Pallerla SR; Amoo AOJ; Thomas BN; Velavan TP; Ojurongbe O
    Infect Genet Evol; 2020 Nov; 85():104503. PubMed ID: 32805431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.